- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs in development for Hepatitis D
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 9, Pages 999-1005
Publisher
Informa UK Limited
Online
2017-07-22
DOI
10.1080/13543784.2017.1357695
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study
- (2017) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
- (2017) Satomi Shimura et al. JOURNAL OF HEPATOLOGY
- HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response
- (2016) G. A. Niro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
- (2016) Andrew Vaillant ANTIVIRAL RESEARCH
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
- (2015) Katja Giersch et al. JOURNAL OF HEPATOLOGY
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
- (2014) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
- (2014) Stephan Urban et al. GASTROENTEROLOGY
- Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
- (2014) Benjamin Heidrich et al. HEPATOLOGY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta
- (2013) Denis Ouzan et al. JOURNAL OF HEPATOLOGY
- Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
- (2013) Shirin Nkongolo et al. JOURNAL OF HEPATOLOGY
- High affinity of copper(II) towards amoxicillin, apramycin and ristomycin. Effect of these complexes on the catalytic activity of HDV ribozyme
- (2013) Kamila Stokowa-Sołtys et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Prime/Boost Immunization with DNA and Adenoviral Vectors Protects from Hepatitis D Virus (HDV) Infection after Simultaneous Infection with HDV and Woodchuck Hepatitis Virus
- (2013) M. Fiedler et al. JOURNAL OF VIROLOGY
- Chronic hepatitis D at a standstill: where do we go from here?
- (2013) Alessia Ciancio et al. Nature Reviews Gastroenterology & Hepatology
- Meta-analysis: antiviral treatment for hepatitis D
- (2012) C. Triantos et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of Chronic Delta Hepatitis
- (2012) Cihan Yurdaydin SEMINARS IN LIVER DISEASE
- Virology of Hepatitis D Virus
- (2012) John Taylor SEMINARS IN LIVER DISEASE
- PEG-IFN for the treatment of hepatitis D
- (2011) Alessia Ciancio et al. Nature Reviews Gastroenterology & Hepatology
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis Delta: Immunopathogenesis and Clinical Challenges
- (2010) Jan Grabowski et al. DIGESTIVE DISEASES
- Hepatitis D: Thirty years after
- (2009) Mario Rizzetto JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now